Bailard’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bailard’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4,200	Closed	-$390K	–	833
2021 Q4	$390K	Buy	+4,200	New	+$277K	0.01%	454
2021 Q3	–	Sell	-5,100	Closed	-$348K	–	781
2021 Q2	$348K	Buy	+5,100	New	+$332K	0.01%	477
2021 Q1	–	Sell	-7,700	Closed	-$592K	–	750
2020 Q4	$592K	Sell	7,700 -2,800	-27%	-$210K	0.03%	290
2020 Q3	$785K	Sell	10,500 -500	-5%	-$33.3K	0.04%	225
2020 Q2	$692K	Hold	11,000	–	–	0.04%	227
2020 Q1	$462K	Sell	11,000 -58,000	-84%	-$2.66M	0.03%	236
2019 Q4	$3.13M	Hold	69,000	–	–	0.18%	119
2019 Q3	$3.16M	Buy	69,000 +10,000	+17%	+$562K	0.19%	111
2019 Q2	$3.46M	Sell	59,000 -8,000	-12%	-$413K	0.21%	101
2019 Q1	$3M	Buy	67,000 +18,000	+37%	+$826K	0.19%	115
2018 Q4	$1.91M	Hold	49,000	–	–	0.13%	152
2018 Q3	$2.25M	Sell	49,000 -3,000	-6%	-$122K	0.13%	150
2018 Q2	$2.27M	Sell	52,000 -33,000	-39%	-$1.42M	0.14%	155
2018 Q1	$3.36M	Buy	85,000 +4,000	+5%	+$156K	0.21%	117
2017 Q4	$2.75M	Buy	+81,000	New	+$2.31M	0.17%	138

Bailard's ARNA Position: Q1 2022 in Review

Bailard sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 4,200 shares — an estimated $390K sold.

Bailard first reported a position in ARNA in Q4 2017 and held it in 15 quarters. The position peaked at $3.46M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Bailard reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Bailard sold 4,200 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $390K.
Bailard first reported a position in Arena Pharmaceuticals Inc in Q4 2017 and held it in 15 quarters.
Bailard's Arena Pharmaceuticals Inc position peaked at $3.46M in Q2 2019.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Bailard's 13F filing for Q1 2022, filed 25 Apr 2022.